Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Aarti Pharmalabs Ltd
Quarter-by-quarter operating performance
| Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 485 | 458 | 440 | 449 | 506 | 555 | 458 | 538 | 564 | 386 | 418 | 432 | 583 |
| Expenses + | 405 | 373 | 352 | 353 | 388 | 459 | 364 | 409 | 418 | 293 | 344 | 330 | 470 |
| Operating Profit | 80 | 85 | 88 | 96 | 118 | 96 | 94 | 129 | 146 | 93 | 74 | 102 | 113 |
| OPM % | 16% | 19% | 20% | 21% | 23% | 17% | 20% | 24% | 26% | 24% | 18% | 24% | 19% |
| Other Income + | 1 | 0 | 1 | 1 | 2 | 2 | 4 | 5 | -2 | 2 | 0 | 2 | 14 |
| Interest | 6 | 4 | 4 | 4 | 5 | 5 | 6 | 10 | 7 | 7 | 11 | 13 | 17 |
| Depreciation | 16 | 17 | 18 | 19 | 19 | 20 | 21 | 23 | 23 | 23 | 25 | 29 | 28 |
| Profit before tax | 59 | 64 | 67 | 74 | 96 | 74 | 72 | 101 | 115 | 65 | 39 | 63 | 82 |
| Tax % | 27% | 26% | 23% | 29% | 32% | 25% | 24% | 26% | 23% | 24% | 28% | 24% | 25% |
| Net Profit + | 43 | 47 | 52 | 53 | 65 | 55 | 55 | 74 | 88 | 50 | 28 | 48 | 61 |
| EPS in Rs | 4.73 | 5.20 | 5.72 | 5.82 | 7.20 | 6.12 | 6.03 | 8.16 | 9.75 | 5.46 | 3.08 | 5.29 | 6.74 |
Financials of Aarti Pharmalabs Ltd
Annual income statement trend
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales + | 0 | 1,200 | 1,945 | 1,853 | 2,115 | 1,819 |
| Expenses + | 0 | 993 | 1,603 | 1,467 | 1,651 | 1,450 |
| Operating Profit | 0 | 207 | 342 | 386 | 464 | 369 |
| OPM % | 17% | 18% | 21% | 22% | 20% | |
| Other Income + | 0 | 3 | 2 | 5 | 10 | 15 |
| Interest | 0 | 12 | 21 | 17 | 27 | 47 |
| Depreciation | 0 | 42 | 63 | 73 | 87 | 104 |
| Profit before tax | 0 | 155 | 261 | 300 | 361 | 233 |
| Tax % | 21% | 26% | 28% | 24% | 25% | |
| Net Profit + | 0 | 122 | 193 | 217 | 272 | 175 |
| EPS in Rs | 21.35 | 23.93 | 30.05 | 19.27 | ||
| Dividend Payout % | 0% | 9% | 13% | 17% | 18% |
Financials of Aarti Pharmalabs Ltd
Capital structure and asset base
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 0.25 | 0.25 | 45 | 45 | 45 | 45 |
| Reserves | -0 | 1,386 | 1,513 | 1,712 | 1,945 | 2,079 |
| Borrowings + | 0 | 341 | 215 | 285 | 413 | 754 |
| Other Liabilities + | 0 | 312 | 470 | 540 | 503 | 603 |
| Total Liabilities | 0 | 2,040 | 2,244 | 2,582 | 2,906 | 3,482 |
| Fixed Assets + | 0 | 782 | 926 | 1,033 | 1,137 | 1,525 |
| CWIP | 0 | 187 | 102 | 137 | 374 | 305 |
| Investments | 0 | 32 | 87 | 107 | 77 | 194 |
| Other Assets + | 0 | 1,038 | 1,130 | 1,305 | 1,319 | 1,457 |
| Total Assets | 0 | 2,040 | 2,244 | 2,582 | 2,906 | 3,482 |
Financials of Aarti Pharmalabs Ltd
Operating, investing and financing cash movement
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 0 | -44 | 250 | 216 | 332 | 262 |
| Cash from Investing Activity + | 0 | -139 | -158 | -215 | -414 | -431 |
| Cash from Financing Activity + | 0 | 260 | -163 | 10 | 65 | 171 |
| Net Cash Flow | 0 | 78 | -71 | 12 | -17 | 2 |
| Free Cash Flow | 0 | -185 | 130 | 18 | -112 | -186 |
| CFO/OP | -11% | 91% | 71% | 85% | 84% |
Financials of Aarti Pharmalabs Ltd
Working capital efficiency and return ratios
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor Days | 115 | 84 | 102 | 99 | 117 | |
| Inventory Days | 272 | 188 | 230 | 190 | 280 | |
| Days Payable | 123 | 106 | 135 | 90 | 146 | |
| Cash Conversion Cycle | 264 | 166 | 197 | 200 | 251 | |
| Working Capital Days | 111 | 94 | 110 | 105 | 90 | |
| ROCE % | 19% | 16% | 17% | 17% | 11% |